Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Clinical trial NCT01473251 · COMPLETED
Trial details
- NCT number
- NCT01473251
- Sponsor
- Vitreo-Retinal Associates, Michigan
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-04-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.